# FDA Inspection 797370 - Sumitomo Dainippon Pharma Co., Ltd. - February 24, 2012

Source: https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/79a8ee81-e677-490a-876d-2756efb285d8
Source feed: FDA_Inspections

> FDA Inspection 797370 for Sumitomo Dainippon Pharma Co., Ltd. on February 24, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 797370
- Company Name: Sumitomo Dainippon Pharma Co., Ltd.
- Inspection Date: 2012-02-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1276963 - 2025-07-11](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/959cb516-78a7-4b4f-96f4-d510481d7ed0)
- [FDA Inspection 1088923 - 2019-04-16](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/7a4e397a-ac18-4bee-996b-e502e1b4dad2)
- [FDA Inspection 1003840 - 2017-02-17](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/5bae5b31-f273-4048-9552-f3d2683edd30)
- [FDA Inspection 895955 - 2014-09-12](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/007e07e2-0c19-4600-a54d-9f4bff03eaf5)
- [FDA Inspection 676813 - 2010-07-30](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/0de6ce2f-082e-4f00-975e-763d7666a5ee)

Company: https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/a14dd605-ff5f-4e7a-a71b-73f6eb72a9c6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c